USA flag logo/image

An Official Website of the United States Government

Transchromosomic Hens Producing Biotherapeutic Drugs

Award Information

Agency:
Department of Agriculture
Branch:
N/A
Award ID:
80923
Program Year/Program:
2006 / SBIR
Agency Tracking Number:
2006-00142
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
AviGenics Inc.
111 Riverbend Rd. 411 MASSACHUSETTS AVENUE Athens, GA 30605 2613
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2006
Title: Transchromosomic Hens Producing Biotherapeutic Drugs
Agency: USDA
Contract: 2006-33610-16842
Award Amount: $80,000.00
 

Abstract:

Basic science discoveries have led to the development of a series of human biotherapeutic drugs for the treatment of cancer and HIV as well as many other diseases. Currently there are over 400 drugs in clinical trials just for the first two diseases. The current biotherapeutics' manufacturing platforms have not kept pace resulting in a dramatic rise in treatment cost and more importantly unmet therapeutic needs. Avian transgenesis is an emerging technology that has the potential to radically increase the US manufacturing capacity of biotherapeuticals. AviGenics, Inc proposes a novel recombinant protein manufacturing platform that will allow us to express human therapeutic molecules in the egg white of hens.

Principal Investigator:

Dawn Eberhardt
7062271170
eberhardt@avigenics.com

Business Contact:

Jim Early
Senior Vice President
2062271170
jearly@avigenics.com
Small Business Information at Submission:

AviGenics, Inc.
111 Riverbend Rd. Athens, GA 30605

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No